Concepedia

Bimal Malhotra

BM

40

Publications

1.6K

Citations

20

H-Index

1994

Active since

Affiliations

Pfizer (United States)(Current)

Pfizer (United Kingdom)

Duke Medical Center

Bristol-Myers Squibb (United States)

UCB Pharma (Germany)

Bimal Malhotra is an author at Pfizer (United States) specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

1994–2022

40

Publications

40

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis

Thomas Bieber, Eric L. Simpson, Jonathan I. Silverberg et al. · New England Journal of Medicine · 2021 · 419 citations · Full text

A comprehensive non‐clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder

Ernesto Callegari, Bimal Malhotra, Peter J. Bungay et al. · British Journal of Clinical Pharmacology · 2011 · 178 citations · Full text

Thorough QT Study with Recommended and Supratherapeutic Doses of Tolterodine

Bimal Malhotra, Paul Glue, Kevin Sweeney et al. · Clinical Pharmacology & Therapeutics · 2007 · 80 citations

, , +9

Pharmacokinetic profile of fesoterodine

Bimal Malhotra, Zhiwei Guan, Nolan Wood et al. · International Journal of Clinical Pharmacology and Therapeutics · 2008 · 70 citations

Evaluation of Cognitive Function in Healthy Older Subjects Treated with Fesoterodine

Gary G. Kay, Paul Maruff, David Scholfield et al. · Postgraduate Medicine · 2012 · 64 citations

Rows per page

1–5 of 40